MAPT and supranuclear palsy, progressive, 1: Together with human post-mortem and patient MRI observations reporting strong correlation between tau pathology and iron deposition in early affected regions—which extends to the cellular and molecular levels via the high co-localization levels of cellular iron and tau cytopathology—the current evidence points to the possible role of iron dysregulation in PSP disease etiology or early disease progression.